Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 3 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Neuropeptide Y: Direct vasoconstrictor and facilitatory effects on P2X1 receptor-dependent vasoconstriction in human small abdominal arteries.
Vascul Pharmacol. 2023 Aug;151:107192. doi: 10.1016/j.vph.2023.107192. Epub 2023 Jul 5.
Vascul Pharmacol. 2023.
PMID: 37419269
Free article.
Structural Basis of the Negative Allosteric Modulation of 5-BDBD at Human P2X4 Receptors.
Bidula S, Nadzirin IB, Cominetti M, Hickey H, Cullum SA, Searcey M, Schmid R, Fountain SJ.
Bidula S, et al.
Mol Pharmacol. 2022 Jan;101(1):33-44. doi: 10.1124/molpharm.121.000402. Epub 2021 Oct 30.
Mol Pharmacol. 2022.
PMID: 34718224
Item in Clipboard
Taspine is a natural product that suppresses P2X4 receptor activity via phosphoinositide 3-kinase inhibition.
Nadzirin IB, Fortuny-Gomez A, Ngum N, Richards D, Ali S, Searcey M, Fountain SJ.
Nadzirin IB, et al.
Br J Pharmacol. 2021 Dec;178(24):4859-4872. doi: 10.1111/bph.15663. Epub 2021 Sep 21.
Br J Pharmacol. 2021.
PMID: 34398973
Free article.
Item in Clipboard
Neuropeptide Y facilitates P2X1 receptor-dependent vasoconstriction via Y1 receptor activation in small mesenteric arteries during sympathetic neurogenic responses.
Gonzalez-Montelongo MDC, Fountain SJ.
Gonzalez-Montelongo MDC, et al.
Vascul Pharmacol. 2021 Feb;136:106810. doi: 10.1016/j.vph.2020.106810. Epub 2020 Nov 9.
Vascul Pharmacol. 2021.
PMID: 33181321
Item in Clipboard
Cite
Cite